Sato, T. et al. 2021. Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19. Journal of Pharmacy & Pharmaceutical Sciences. 24, (May 2021), 227–236. DOI:https://doi.org/10.18433/jpps31813.